Swiss researchers discover antibody signature that could predict Long Covid
Long Covid patients often report symptoms such as fatigue, difficulty breathing, cognitive impairment and muscle weakness more than four weeks after the initial infection.
Keystone / Alessandro Crinari
Immunologists at the University Hospital Zurich found lower levels of two types of immunoglobulins among patients who developed post-acute Covid-19 syndrome, also known as Long Covid.
This content was published on
2 minutes
Keystone-SDA/swissinfo.ch/gw
العربية
ar
اكتشاف بصمات أجسام مضادة قد تكون المسببة لإصابات كوفيد طويلة الأمد
Normally levels of immunoglobulins IgM and IgG3 – antibodies produced by the immune system to fight infections – rise when a person catches Covid. But, along with risk factors such as age and a history of asthma, Zurich researchers detected lower levels of IgM and IgG3 in those Covid patients who still reported symptoms after four weeks. This has led the doctors to conclude that developing Long Covid correlates with a distinct Ig or antibody signature.
Their study, published this weekExternal link in the journal Nature Communications, followed 175 people who tested positive for Covid in the first wave of the pandemic. Forty other people who did not have the disease served as the control group.
The findings suggest that one cause of Long Covid, a little understood condition for which no standard definition or treatment exists, could be a misdirected immune response.
“This opens up possibilities for targeted treatments, such as the administration of certain immunoglobulins or immunomodulatory drugs,” lead researcher Odur Boyman told the Keystone-SDA news agency.
The best protection against Long Covid, however, is vaccination, said Boyman, because it reduces the risk of rapid viral replication and therefore a misdirected immune response.
The researchers have used their findings to develop a new model or score to calculate Long Covid risk that combines the antibody signature with age and a history of asthma in the patient. Determining immunoglobulin levels for the model can be done cheaply and easily, according to Boyman. The model was tested on another group of 395 Covid patients.
Popular Stories
More
Multinational companies
Azeri fossil-fuel cash cow brings controversy to Switzerland
Swiss price watchdog slams excessive prices for generic medicines
This content was published on
The cheapest generic medicines available in Switzerland are more than twice as expensive as in other countries, according to a study by the Swiss price watchdog.
Nature should not figure in net zero calculations: academic study
This content was published on
The natural removal of CO2 from the atmosphere by forests or oceans should not be included in the net-zero balance of climate protection measures, argue researchers.
This content was published on
None of the 15 major Swiss retail banks is meeting international climate and biodiversity targets, according to a ranking by WWF Switzerland.
This content was published on
Nestlé's new CEO Laurent Freixe, has presented plans for the future of the world's largest food company, after his first few weeks in office.
Swiss foreign minister calls on Moscow to end Ukraine war
This content was published on
It's high time Moscow ended its war against Ukraine, Swiss foreign minister Ignazio Cassis tells the UN Security Council.
This content was published on
The only alternative to the UN Palestinian agency’s work in Gaza is to allow Israel to run services there, Philippe Lazzarini, UNRWA Commissioner-General, told reporters in Geneva on Monday.
Study reveals food culture differences between Switzerland and neighbours
This content was published on
Three-quarters of Swiss people consider eating to be a pleasurable, social activity, a new survey reveals. Healthy eating, however, plays a much less important role, it found.
Doctors demand better co-ordination to solve Long Covid problems
This content was published on
Calls are growing for Switzerland to keep better track of people suffering from Long Covid to get a better understanding of the symptoms and the overall impact on society.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.